“Emergent is excited about this new facility in Baltimore because it houses several suites capable of manufacturing multiple products at the same time,” said Fuad El-Hibri, chairman and chief executive officer of Emergent BioSolutions. “Accordingly, this facility will provide the flexibility to conduct large-scale manufacturing of rPA while also producing other products in our pipeline.”

Ever since the dot-COM bubble burst almost ten years ago, Maryland has been bragging about how biotech would not only become the next big thing in innovation and business but would put Maryland on the map. Well, while it has mostly been hyperbole, Rockville, Maryland, based Emergent BioSolutions has been the bright-burning exception under the leadership of Chairman and CEO, Mr. Fuad El-Hibri. Well, Ernst & Young has named Fuad El-Hibri the Ernst & Young Entrepreneur of the Year 2009. (Via Chris Abraham)